ARTICLE | Company News
Montigen Pharmaceuticals, SuperGen deal
April 10, 2006 7:00 AM UTC
SUPG completed its previously announced acquisition of cancer company Montigen for $18 million in stock and cash (see BioCentury, Jan. 30). Montigen shareholders are eligible for up to $22 million in ...